Cargando…

Association Between Use of Pharmacokinetic‐Interacting Drugs and Effectiveness and Safety of Direct Acting Oral Anticoagulants: Nested Case‐Control Study

Concomitant use of direct oral anticoagulants (DOACs) and medications with inhibition/induction effect on P‐gp/CYP3A might increase risk of bleeding/treatment failure, respectively. We designed a nested case‐control study within a Clalit cohort of patients with atrial fibrillation (AF) and a cohort...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gronich, Naomi, Stein, Nili, Muszkat, Mordechai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290518/ https://www.ncbi.nlm.nih.gov/pubmed/34287842 http://dx.doi.org/10.1002/cpt.2369

Ejemplares similares

Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study
por: Gronich, Naomi, et al.
Publicado: (2022)

Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation
por: Raccah, Bruria Hirsh, et al.
Publicado: (2021)

Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
por: Galgani, Alessandro, et al.
Publicado: (2018)

Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program
por: Perlman, Amichai, et al.
Publicado: (2019)

Corrigendum: Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
por: Galgani, Alessandro, et al.
Publicado: (2020)

Medications that interact with direct-acting oral anticoagulant exposure
por: de Vries, T. A. C., et al.
Publicado: (2021)

Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C)
por: Kravchenko, Olga V, et al.
Publicado: (2022)

Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
por: Doucette, Kimberley, et al.
Publicado: (2020)

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

Effect of Enzyme-Inducing Antiseizure Medications on the Risk of Sub-Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study
por: Perlman, Amichai, et al.
Publicado: (2021)

The effect of multidrug exposure on neurological manifestations in carbamazepine intoxication: a nested case-control study
por: Hirsch, Ayala, et al.
Publicado: (2020)

Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review
por: Bellesini, Marta, et al.
Publicado: (2020)

Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019)

The Clinical Significance of Drug–Food Interactions of Direct Oral Anticoagulants
por: Grześk, Grzegorz, et al.
Publicado: (2021)

Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
por: Al Rowily, Abdulrhman, et al.
Publicado: (2023)

Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population‐based nested case–control study
por: Zhang, Yumao, et al.
Publicado: (2020)

Drug-drug interactions in atrial fibrillation patients receiving direct oral anticoagulants
por: Lee, Ji Yun, et al.
Publicado: (2021)

Drug interactions of direct oral anticoagulants in elderly patients with cardiometabolic diseases
por: Bellia, Alfonso, et al.
Publicado: (2021)

Efficacy and Safety of Direct-Acting Oral Anticoagulants Use in Acute Portal Vein Thrombosis Unrelated to Cirrhosis
por: Nery, Filipe, et al.
Publicado: (2017)

Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis
por: Davis, Estella, et al.
Publicado: (2020)

Five-Year Trends in Potential Drug Interactions with Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation: An Australian-Wide Study
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2020)

Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants
por: Gao, Lulu, et al.
Publicado: (2017)

Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome
por: Sexton, Donal J., et al.
Publicado: (2018)

Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians
por: Peacock, W. Frank, et al.
Publicado: (2016)

Adding Herbal Products to Direct-Acting Oral Anticoagulants Can Be Fatal
por: Maadarani, Ossama, et al.
Publicado: (2019)

The use of direct acting oral anticoagulants in patients with COVID-19 infection
por: Aly, Ragia, et al.
Publicado: (2021)

Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review
por: Górnicki, Tomasz, et al.
Publicado: (2023)

Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice
por: Ferri, Nicola, et al.
Publicado: (2022)

Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review
por: Candeloro, Matteo, et al.
Publicado: (2023)

Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
por: Rose, Adam J., et al.
Publicado: (2021)

Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
por: Abdelnabi, Mahmoud, et al.
Publicado: (2022)

The efficacy and safety of out-hospital anticoagulation therapy with direct oral anticoagulant for COVID-19
por: Geng, Yu, et al.
Publicado: (2023)

Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Antivirals/direct oral anticoagulants interaction: Anticoagulation drug level increased and off label use: 12 case reports
Publicado: (2020)

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2020)

Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia
por: Shovlin, C. L., et al.
Publicado: (2019)

Safety of direct oral anticoagulants in patients with advanced liver disease
por: Semmler, Georg, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ie08kqvftqtv6c1nama0pihkuh